COMMUNIQUÉS West-GlobeNewswire
-
ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500 for Prader-Willi Syndrome
16/06/2026 -
Sanuwave Health Updates Second Quarter 2026 Guidance
16/06/2026 -
NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure
16/06/2026 -
First Steps Developmental Services Expands School Partnership Program to Support Massachusetts Students and Educators
16/06/2026 -
Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD
16/06/2026 -
Through the MUHC Foundation, one family helps fuel breakthrough in rare cancer research
16/06/2026 -
Sharecare selected by Georgia Department of Community Health to advance rural health transformation through GREAT Health Program
16/06/2026 -
Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry
16/06/2026 -
Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044
16/06/2026 -
WORK Medical Announces 1-for-100 Reverse Stock Split Effective June 18, 2026
16/06/2026 -
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16/06/2026 -
Breckenridge Brewery Launches a Colorado-Wide Soccer Celebration with Fan-First Activations
16/06/2026 -
My Derma Dream MyoGlow Examined 2026 - Why Is the MyoGlow Arm Device Getting So Much Attention Across the United States?
16/06/2026 -
VitalHub Announces Deployments of Referral Management Solutions
16/06/2026 -
nCAP Medical Announces Publication of Positive RCT Results Demonstrating NeuroCuple® Provides Meaningful, Opioid-Sparing Pain Relief Immediately Following Total Knee Arthroplasty
16/06/2026 -
Weston Family Foundation invests an additional $37 million to safeguard one of Canada’s most ecologically valuable and threatened ecosystems
16/06/2026 -
Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water
16/06/2026 -
Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody
16/06/2026 -
Transactions in connection with share buy-back program
16/06/2026
Pages